PL365000A1 - Agent for treating hepatitis c containing ukrain - Google Patents

Agent for treating hepatitis c containing ukrain

Info

Publication number
PL365000A1
PL365000A1 PL01365000A PL36500001A PL365000A1 PL 365000 A1 PL365000 A1 PL 365000A1 PL 01365000 A PL01365000 A PL 01365000A PL 36500001 A PL36500001 A PL 36500001A PL 365000 A1 PL365000 A1 PL 365000A1
Authority
PL
Poland
Prior art keywords
ukrain
agent
treating hepatitis
hepatitis
treating
Prior art date
Application number
PL01365000A
Other languages
English (en)
Polish (pl)
Inventor
Wassyl Nowicky
Original Assignee
Wassyl Nowicky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wassyl Nowicky filed Critical Wassyl Nowicky
Publication of PL365000A1 publication Critical patent/PL365000A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL01365000A 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain PL365000A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (fr) 2000-03-22 2001-03-20 Agent de traitement de l'hepatite c

Publications (1)

Publication Number Publication Date
PL365000A1 true PL365000A1 (en) 2004-12-27

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365000A PL365000A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain

Country Status (17)

Country Link
JP (1) JP2003527414A (fr)
KR (1) KR20020087045A (fr)
CN (1) CN1416347A (fr)
AT (1) AT408719B (fr)
AU (1) AU2001239000A1 (fr)
BG (1) BG107088A (fr)
BR (1) BR0107211A (fr)
CA (1) CA2389173A1 (fr)
EA (1) EA200200584A1 (fr)
HR (1) HRP20020367A2 (fr)
IL (1) IL149314A0 (fr)
IS (1) IS6360A (fr)
MA (1) MA25509A1 (fr)
MX (1) MXPA02004993A (fr)
NO (1) NO20022253L (fr)
PL (1) PL365000A1 (fr)
WO (1) WO2001070203A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (fr) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Dérivés quaternaires de chelidonine et d'alkaloides, procédé pour leur préparation et leur utilisation dans la préparation de médicaments
CA2664935A1 (fr) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions de traitement de l'hepatite c et procedes d'utilisation des compositions de traitement de l'hepatite c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
HRP20020367A2 (en) 2004-02-29
IL149314A0 (en) 2002-11-10
KR20020087045A (ko) 2002-11-21
NO20022253D0 (no) 2002-05-10
WO2001070203A2 (fr) 2001-09-27
EA200200584A1 (ru) 2003-06-26
NO20022253L (no) 2002-05-10
ATA4812000A (de) 2001-07-15
BR0107211A (pt) 2004-01-06
CA2389173A1 (fr) 2001-09-27
CN1416347A (zh) 2003-05-07
AU2001239000A1 (en) 2001-10-03
JP2003527414A (ja) 2003-09-16
MXPA02004993A (es) 2003-10-14
MA25509A1 (fr) 2002-07-01
BG107088A (en) 2003-05-30
IS6360A (is) 2002-04-24
AT408719B (de) 2002-02-25
WO2001070203A3 (fr) 2002-09-06

Similar Documents

Publication Publication Date Title
EP1429759A4 (fr) Composes pour traiter le virus de l'hepatite c
IL141011A0 (en) Hepatitis c inhibitor peptides
EP1349851A4 (fr) Composes
GB0118884D0 (en) Apparatus for treating objects
SG101494A1 (en) Exposure method
AP2000001871A0 (en) Chemical agent for stabilizing soil
GB0118349D0 (en) Apparatus for treating objects
GB0118881D0 (en) Apparatus for treating objects
EG24462A (en) Compounds for treating fundic disaccomodation
AU2405002A (en) Dehalogeno compounds
PL365000A1 (en) Agent for treating hepatitis c containing ukrain
GB0121048D0 (en) Apparatus for treating objects
GB0118883D0 (en) Method for treating objects
GB0123898D0 (en) Method for treating objects
AU138774S (en) Distiller
GB0122810D0 (en) Method for treating objects
GB0123897D0 (en) Method for treating objects
GB9823835D0 (en) Component for vaccine
GB0007652D0 (en) Treatment for fabrics
GB0030956D0 (en) Stain treatment composition
GB0024364D0 (en) Method for treating stained materials
AU4497999A (en) Radioimmunopharmaca for treating hepatitis c
PL332125A1 (en) Softeningh agent for textiles
GB9822887D0 (en) Hand garment for snowmobiles
GB0007483D0 (en) Detoxification process

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)